1. Home
  2. BOLT vs INHD Comparison

BOLT vs INHD Comparison

Compare BOLT & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • INHD
  • Stock Information
  • Founded
  • BOLT 2015
  • INHD 2019
  • Country
  • BOLT United States
  • INHD United States
  • Employees
  • BOLT N/A
  • INHD N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • BOLT Health Care
  • INHD
  • Exchange
  • BOLT Nasdaq
  • INHD Nasdaq
  • Market Cap
  • BOLT 16.8M
  • INHD 19.8M
  • IPO Year
  • BOLT 2021
  • INHD 2023
  • Fundamental
  • Price
  • BOLT $0.37
  • INHD $7.27
  • Analyst Decision
  • BOLT Hold
  • INHD
  • Analyst Count
  • BOLT 5
  • INHD 0
  • Target Price
  • BOLT $1.13
  • INHD N/A
  • AVG Volume (30 Days)
  • BOLT 145.0K
  • INHD 39.1K
  • Earning Date
  • BOLT 05-13-2025
  • INHD 05-12-2025
  • Dividend Yield
  • BOLT N/A
  • INHD N/A
  • EPS Growth
  • BOLT N/A
  • INHD N/A
  • EPS
  • BOLT N/A
  • INHD N/A
  • Revenue
  • BOLT $7,690,000.00
  • INHD $916,878.00
  • Revenue This Year
  • BOLT N/A
  • INHD N/A
  • Revenue Next Year
  • BOLT $77.45
  • INHD N/A
  • P/E Ratio
  • BOLT N/A
  • INHD N/A
  • Revenue Growth
  • BOLT N/A
  • INHD 39.48
  • 52 Week Low
  • BOLT $0.30
  • INHD $3.00
  • 52 Week High
  • BOLT $1.34
  • INHD $10.23
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 48.52
  • INHD 67.11
  • Support Level
  • BOLT $0.33
  • INHD $5.22
  • Resistance Level
  • BOLT $0.39
  • INHD $10.23
  • Average True Range (ATR)
  • BOLT 0.04
  • INHD 0.64
  • MACD
  • BOLT 0.00
  • INHD 0.24
  • Stochastic Oscillator
  • BOLT 66.06
  • INHD 47.47

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: